Redox Biomarkers – An Effective Tool for Diagnosing COVID-19 Patients and Convalescents
Blanka Wolszczak-Biedrzycka,Justyna Dorf,Joanna Matowicka-Karna,Violetta Dymicka-Piekarska,Marzena Wojewódzka-Żeleźniakowicz,Piotr Żukowski,Anna Zalewska,Łukasz Dąbrowski,Mateusz Maciejczyk
DOI: https://doi.org/10.2147/jir.s456849
IF: 4.5
2024-04-27
Journal of Inflammation Research
Abstract:Blanka Wolszczak-Biedrzycka, 1 Justyna Dorf, 2 Joanna Matowicka-Karna, 2 Violetta Dymicka-Piekarska, 2 Marzena Wojewódzka-&Zdotele&zacuteniakowicz, 3 Piotr &Zdotukowski, 4 Anna Zalewska, 5 &Lstrokukasz D&aogonbrowski, 6 Mateusz Maciejczyk 7 1 Department of Psychology and Sociology of Health and Public Health, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland; 2 Department of Clinical Laboratory Diagnostics, Medical University of Bialystok, Bialystok, Poland; 3 Department of Emergency Medicine and Disasters, Medical University of Bialystok, Bialystok, Poland; 4 Department of Restorative Dentistry, Croydon University Hospital, London, UK; 5 Independent Laboratory of Experimental Dentistry, Medical University of Bialystok, Bialystok, Poland; 6 Medical Laboratory, "Diagnostyka" Olsztyn, Olsztyn, Poland; 7 Department of Hygiene, Epidemiology and Ergonomics, Medical University of Bialystok, Bialystok, Poland Correspondence: Blanka Wolszczak-Biedrzycka, Email Aim: COVID-19 triggers the overproduction of reactive oxygen species (ROS) which, in combination with a weakened antioxidant barrier, can lead to protein oxidation and lipid peroxidation. The aim of this study was to evaluate enzymatic and non-enzymatic antioxidants, the overall redox potential, and protein and lipid peroxidation products in COVID-19 patients, convalescents, and healthy subjects, and to the determine the diagnostic applicability of these parameters in COVID-19 patients. Materials and Methods: The study involved 218 patients with COVID-19, 69 convalescents, and 48 healthy subjects who were selected for the research based on age and sex. The study was conducted between 20 February 2021 and 20 November 2021 in Bia&lstrokystok, Poland. The antioxidant barrier, redox status, and oxidative damage products were assessed in serum/plasma samples with the use of colorimetric and spectrophotometric assays. Results: Glutathione reductase (GR) activity was higher, whereas total antioxidant capacity (TAC) was lower in COVID-19 patients than in convalescents (p< 0.0001) and the control group (p< 0.0001). The concentrations of advanced glycation end products (AGEs), advanced oxidation protein products (AOPP), 4-hydroxynonenal (4-HNE), and malondialdehyde (MDA) were higher in COVID-19 patients (p< 0.0001) and convalescents (p< 0.0001) than in the control group. AGEs were the most effective diagnostic biomarker for differentiating COVID-19 patients from the control group (AUC=0.9971) and convalescents from the control group (AUC=1.000). Conclusion: An infection with the SARS-CoV-2 disrupts the redox balance and increases protein oxidation and lipid peroxidation. AGEs fulfill the criteria for a potential diagnostic biomarker in COVID-19 patients and convalescents. Keywords: oxidative stress, redox biomarkers, antioxidants, COVID-19, SARS CoV-2 virus The pathogenesis of the infection caused by the SARS-CoV-2 has not been fully elucidated to date. The immune response to the infection is complex and highly individualized, which undoubtedly affects the severity of disease symptoms and complications after the infection. 1 Research has shown that severe COVID-19 is not directly caused by the SARS-CoV-2, but by the cytokine storm which increases the production of reactive oxygen species (ROS) that induce oxidative stress. 2 An infection caused by the SARS-CoV-2 leads to the activation of neutrophils and mononuclear phagocytic cells which are largely responsible for the massive release of ROS in lung tissues. 3 In addition, the SARS-CoV-2 reaches lung cells via the angiotensin-converting enzyme 2 (ACE2) receptor, and an imbalance between the rate of ROS production and antioxidant processes may lead to oxidative damage to proteins, lipids, and nucleic acids. 4 Glutathione (GSH) is one of the key components of the antioxidant barrier, and it can prevent the S1 subunit of the SARS-CoV-2 spike protein from binding to the ACE2 receptor in the lungs. 5 According to the literature, an endogenous deficiency of GSH and other antioxidants, including superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase (GR), can affect the severity of COVID-19. 6 It is generally known that COVID-19 can lead to post-infection complications and increases the risk of inflammatory, 7,8 metabolic, and neurodegenerative diseases which are also caused by an oxidation-reduction (redox) imbalance. 9 Therefore, oxidative stress parameters and antioxidant levels should be compared in convalesce -Abstract Truncated-
immunology